Tumor biomarkers: Help or mislead in the diagnosis of xanthogranulomatous cholecystitis?-analysis of serum CA 19-9, carcinoembryonic antigen, and CA 12-5

Chinese Medical Journal

Volumn 126, Issue 16, 2013, Pages 3044-3047

  Yu, Hong ^a   Yu, Tu Nan ^a   Cai, Xiu Jun ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

CA 19 9 antigen; Gallbladder neoplasms; Xanthomatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ARTICLE; CHOLECYSTITIS; CLINICAL ARTICLE; COMMON BILE DUCT STONE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; FEMALE; GIANT CELL; HISTIOCYTE; HUMAN; INFLAMMATORY CELL; LIVER FUNCTION TEST; MALE; MIRIZZI SYNDROME; XANTHOGRANULOMATOUS CHOLECYSTITIS;

ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHOLECYSTITIS; FEMALE; GRANULOMA; HUMANS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; XANTHOMATOSIS;

EID: 84882243914     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20120341     Document Type: Article

References (20)

1. Guzman-Valdivia G. Xanthogranulomatous cholecystitis: 15 years' experience. World J Surg 2004; 28: 254-257.
2. Mccoy JJ Jr., Vila R, Petrossian G, Mccall RA, Reddy KS. Xanthogranulomatous cholecystitis. Report of two cases. J S C Med Assoc 1976; 72: 78-79.
3. Solanki RL, Arora HL, Gaur SK, Anand VK, Gupta R. Xantho-granulomatous cholecystitis (XGC): a clinicopathological study of 21 cases. Indian J Pathol Microbiol 1989; 32: 256-260.
4. Zhang LF, Hou CS, Liu JY, Xiu DR, Xu Z, Wang LX, et al. Strategies for diagnosis of xanthogranulomatous cholecystitis masquerading as gallbladder cancer. Chin Med J 2012; 125: 109-113.
5. Shih SP, Schulick RD, Cameron JL, Lillemoe KD, Pitt HA, Choti MA et al. Gallbladder cancer: the role of laparoscopy and radical resection. Ann Surg 2007; 245: 893-901.
6. Kim HJ, Kim MH, Myung SJ, Lim BC, Park ET, Yoo KS, et al. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve. Am J Gastroenterol 1999; 94: 1941-1946.
7. Shukla VK, Gurubachan, Sharma D, Dixit VK, Usha. Diagnostic value of serum CA242, CA 19-9, CA 15-3 and CA 125 in patients with carcinoma of the gallbladder. Trop Gastroenterol 2006; 27: 160-165.
8. Omar YT, al-Naqeeb N, El Nas SA, Awwad AH, Foudeh MO, Safadi NB, et al. Serum levels of CA 125 in patients with gastrointestinal cancers. Tumour Biol 1989; 10: 316-323.
9. Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol 2007; 33: 266-270.
10. Hatzaras I, Schmidt C, Muscarella P, Melvin WS, Ellison EC, Bloomston M. Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies. HPB (Oxford) 2010; 12: 134-138.
11. Mol BW, Bayram N, Lijmer JG, Wiegerinck MA, Bongers MY, van der Veen F, et al. The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril 1998; 70: 1101-1108.
12. Guzman-Valdivia G. Xanthogranulomatous cholecystitis in lapa-roscopic surgery. J Gastrointest Surg 2005; 9: 494-497.
13. Balague C, Targarona EM, Sugranes G, Rey MJ, Arce Y, Viella P, et al. Xanthogranulomatous cholecystitis simulating gallbladder neoplasm: therapeutic implications. Gastroenterol Hepatol 1996; 19: 503-506.
14. Liang JW, Dong SX, Zhou ZX, Tian YT, Zhao DB, Wang CF, et al. Surgical management for carcinoma of the gallbladder: a single-institution experience in 25 years. Chin Med J 2008; 121: 1900-1905.
15. Feng FL, Liu C, Li B, Zhang BH, Jiang XQ. Role of radical resection in patients with gallbladder carcinoma and jaundice. Chin Med J 2012; 125: 752-756.
16. Enomoto T, Todoroki T, Koike N, Kawamoto T, Matsumoto H. Xanthogranulomatous cholecystitis mimicking stage IV gallbladder cancer. Hepatogastroenterology 2003; 50: 1255-1258.
17. Chakravarty KD, Yeh CN, Jan YY, Chen MF. Factors influencing long-term survival in patients with T3 gallbladder adenocar-cinoma. Digestion 2009; 79: 151-157.
18. Chaube A, Tewari M, Singh U, Shukla HS. CA 125: a potential tumor marker for gallbladder cancer. J Surg Oncol 2006; 93: 665-669.
19. Marrelli D, Caruso S, Pedrazzani C, Neri A, Fernandes E, Marini M, et al. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions. Am J Surg 2009; 198: 333-339.
20. Wen H, Yoo SS, Kang J, Kim HG, Park JS, Jeong S, et al. A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer. J Hepatol 2010; 52: 228-233.